Lifeforce Capital Management, LLC

Emerging manager

SEC exempt reporting adviser (venture capital exemption).

Lifeforce Capital Management, LLC invests in software companies that are reshaping the status quo in healthcare's largest markets.

01 · Says / Does

Tag	Says	Does	Historically (to 2020)
Stages	Not stated	Not enough dated deals	Series A, Growth, Series B
Sectors	Healthtech	Not enough dated deals	Healthtech, Biotech, Digital health, Medical devices, Enterprise SaaS, Consumer
Regions	Not stated	Not enough dated deals	CA

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

Historical focus (through 2020), derived from historical deal data.

Year	Deals	Top sectors
2014	3	Healthtech, Digital health, Medical devices
2015	3	Healthtech, Enterprise SaaS
2016	3	Biotech, Healthtech, Digital health
2017	4	Biotech, Healthtech, Enterprise SaaS
2018	8	Healthtech, Biotech, Digital health
2019	2	Biotech, Healthtech
2020	4	Biotech, Healthtech, Consumer

Share of rounds by stage, per year. Striped years have fewer than 3 rounds.Historical focus (through 2020), derived from historical deal data.

Rounds by stage and year
Year	Seed	Series A	Series B	Growth
2014	1	0	0	2
2015	0	0	1	2
2016	0	1	1	0
2017	0	2	1	1
2018	1	6	1	0
2019	0	1	1	0
2020	0	2	1	1
2021	0	0	0	0
2022	0	0	0	0
2023	0	0	0	0
2024	0	0	0	0
2025	0	0	0	0
2026	0	0	0	0

Fund	Year	Size	Status
LFC LifeCycle VIII, LLC Lifeforce Capital invests in software companies reshaping the status quo in healthcare's largest markets. Its portfolio spans digital health, AI applications, and healthcare-focused biotech and medtech companies. Inferred from the firm's website	approx. 2026	$5M (Form D)	Raising

John Noonan, Managing Member of Managing Member of the Issuer
LFC LifeCycle VIII, LLC (Named on Form D)

No dated deals found yet.

No news from the firm's website yet.

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026